EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Acute TREM2 inhibition depletes MAFB-high microglia and hinders remyelination

Jinchao Hou, Roberta Magliozzi, Yun Chen, Junjie Wu iD, John Wulf, Gregory Strout, Xiangming Fang iD, Marco Colonna iD

Proceedings of the National Academy of Sciences · 2025-04 · 122 (13)

DOI: 10.1073/pnas.2426786122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 25.03.2025. Verfasst von Jinchao Hou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzh…. Hauptthemen laut MEDLINE: Receptors, Immunologic, Membrane Glycoproteins, Microglia, Remyelination. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cure Alzheimer's Fund (CAF), NIA NIH HHS, Fred and Ginger Haberle Charitable Fund at East Texas Communities Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We investigated the role of Triggering Receptor Expressed on Myeloid cells 2 (TREM2) in myelin regeneration in the brain. TREM2 is a receptor that activates microglia, which are crucial for clearing myelin debris and promoting remyelination. Previous studies in a mouse model of demyelination induced by the copper-chelating agent Cuprizone (CPZ) have shown that stimulation of TREM2 with a monoclonal antibody reduces demyelination, while deleting the Trem2 gene in mice impairs remyelination. Here, we blocked TREM2 function acutely with an antibody during both the demyelination and remyelination phases of the CPZ model and analyzed the impact of the antibody treatment on myelination and gene expression in single cells. We found that blocking TREM2 depleted a distinct population of microglia with high expression of the transcription factor MAFB during remyelination. The loss of these MAFB-high microglia was linked to impaired generation of myelinating oligodendrocytes. Importantly, we identified MAFB + microglia in acute and acute-chronic brain lesions from individuals with multiple sclerosis (MS), but not in inactive lesions. We conclude that TREM2 is essential for maintaining a population of MAFB-high microglia that is associated with myelin repair. This finding has significant implications for understanding demyelinating diseases like MS and suggests that stimulating TREM2 could be a promising therapeutic approach for myelin repair.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, ImmunologicMembrane GlycoproteinsMicrogliaRemyelinationMafB Transcription FactorDemyelinating DiseasesMyelin SheathAnimalsMiceCuprizoneMultiple SclerosisOligodendrogliaHumansMice, Inbred C57BLDisease Models, AnimalBrain

Stichwörter der Autor:innen

TREM2microgliamultiple sclerosismyelintranscription factor

Substanzen

Receptors, ImmunologicMembrane GlycoproteinsTrem2 protein, mouseMafB Transcription FactorCuprizoneMafb protein, mouseTREM2 protein, human

Autor:innen und Institutionen

  • Department of Anesthesiology, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310052, China.
  • Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, St. Louis, MO 63110.
  • Department of Brain Sciences, Faculty of Medicine, Imperial College London, London W12 0NN, United Kingdom.
  • Neurology Section of Department of Neuroscience, Biomedicine and Movement, University of Verona, Verona 371734, Italy.
  • Department of Neurology, Washington University School of Medicine, St. Louis, MO 63110.
  • Department of Mechanical Engineering and Materials Science, Washington University, St. Louis, MO 63110.

ORCID-Profile: Junjie Wu, Xiangming Fang, Marco Colonna

Förderung

  • Cure Alzheimer's Fund (CAF)
  • NIA NIH HHS
  • Fred and Ginger Haberle Charitable Fund at East Texas Communities Foundation
  • HHS | NIH | National Institute on Aging

Zitieren

APA

Hou, J., Magliozzi, R., Chen, Y., Wu, J., Wulf, J., Strout, G., Fang, X., & Colonna, M. (2025). Acute TREM2 inhibition depletes MAFB-high microglia and hinders remyelination. Proceedings of the National Academy of Sciences, 122(13). https://doi.org/10.1073/pnas.2426786122

Vancouver

Hou J, Magliozzi R, Chen Y, Wu J, Wulf J, Strout G, et al. Acute TREM2 inhibition depletes MAFB-high microglia and hinders remyelination. Proceedings of the National Academy of Sciences. 2025;122(13). doi:10.1073/pnas.2426786122

BibTeX
@article{Hou2025,
  author = {Hou, Jinchao and Magliozzi, Roberta and Chen, Yun and Wu, Junjie and Wulf, John and Strout, Gregory and Fang, Xiangming and Colonna, Marco},
  title = {Acute TREM2 inhibition depletes MAFB-high microglia and hinders remyelination},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  volume = {122},
  number = {13},
  doi = {10.1073/pnas.2426786122}
}
Kostenlos starten →